参考文献/References:
[1] Sawynok J. Topical and peripheral ketamine as an analgesic [J].Anesth Analg, 2014, 119(1): 170-178.
[2] Hoskins R.Ketamine associated cystitis：a case report [J]. Int Emerg Nurs, 2009, 17(1): 69-71.
[3] 王艳芬, 张玉竹, 连智, 等. 北京地区三种新型毒品流行滥用特征[J]. 中国药物依赖性杂志, 2008, 17(6): 445-454, 459.
[4] Bokor G, Anderson PD. Ketamine:an update on its abuse [J]. J Pharm Pract, 2014, 27(6): 582-586.
[5] Shahani R, Streutker C, Dickson B, et al. Ketamine-associated ulcerative cystitis: a new clinical entity [J]. Urology, 2007, 69(5):810-812.
[6] Chu PK, Kwok SC, Lam KM, et al. Street ketamine-associated bladder dysfunction:a report of ten cases [J]. Hong Kong Med J,2007, 13(4): 311-313.
[7] Chen CH, Lee MH, Chen YC, et al. Ketamine-snorting associated cystitis[J]. J Formos Med Assoc, 2011, 110(12): 787-791．
[8] Winstock AR, Mitcheson L, Gillatt DA, et al. The prevalence and natural history of urinary symptoms among recreational ketamine users[J]. BJU Int, 2012, 110(11): 1762-1766.
[9] Pal R, Balt S, Erowid E, et al. Ketamine is associated with lower urinary tract signs and symptoms[J]. Drug Alcohol Depend, 2013,132(1/2): 189-194.
[10] Mion G, Villevieille T. Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)[J].CNS Neurosci Ther, 2013, 19(6):370-380.
[11] Chen JT, Chen RM. Mechanisms of ketamine-involved regulation of cytochrome P450 gene expression[J].Expert Opin Drug Metab Toxicol, 2010, 6(3):273-281.
[12] Adamowicz P, Kala M. Urinary excretion rates of ketamine and norketamine following therapeutic ketamine administration:method and detection window considerations [J]. J Anal Toxicol,2005, 29(5): 376-382.
[13] Moore KA, Sklerov J, Levine B, et al．Urine concentrations of ketamine and norketamine following illegal consumption [J]. J Anal Toxicol, 2001, 25(7): 583-588.
[14] Gu D, Huang J, Yin Y, et al. Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier [J]. Mol Biol Rep, 2014, 41(11): 7313-7322.
[15] Lee CL, Jiang YH, Kuo HC. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls[J] BJU Int, 2013, 112(8): 1156-1162.
[16] Liu HT, Shie JH, Chen SH, et al. Differences in mast cell infiltration, e-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome[J]. Urology, 2012, 80(1): e13-e18.
[17] Chuang FC, Kuo HC. Increased urothelial cell apoptosis and chronic inflammation are associated with recurrent urinary tract infection in women[J]. PLoS One, 2013, 8(5): e63760.
[18] Scallet AC, Schmued LC, Slikker W Jr, et al. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons [J]. Toxicol Sci, 2004, 81: (2), 364-370.
[19] Ricci V, Martinotti G, Gelfo F, et al. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor [J] Psychopharmacology (Berl), 2011, 215(1): 143-148.
[20] Jiang YH, Liu HT, Kuo HC. Decrease of urinary nerve growth factor but notbrain-derived neurotrophic factor in patients with interstitial cystitis/bladderpain syndrome treated with hyaluronic acid[J]. PLoS One, 2014, 9(3): e91609.
[21] Cruz CD. Neurotrophins in bladder function: what do we know and where do we go from here? [J]. Neurourol Urodyn, 2014, 33 (1): 39-45.
[22] Meng E, Chang HY, Chang SY, et al. Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction [J]. J Urol, 2011, 186(3): 1134-1141.
[23] Wei YB, Yang JR, Yin Z, et al. Genitourinary toxicity of ketamine [J]. Hong Kong Med J, 2013, 19(4): 341-348.
[24] Jhang JF, Hsu YH, Jiang YH, et al. Elevated serum IgE may be associated with development of ketamine cystitis[J]. J Urol, 2014,192(4): 1249-1256.
[25] Zamora R, Vodovotz Y, Billiar TR. Inducible nitric oxide synthase andinflammatory diseases[J]. Mol Med, 2000, 6(5): 347-373.
[26] 祝艳翠, 衡新华. 氯胺酮抗炎作用机制的研究进展[J]. 医学信息, 2012, 25(12): 446-447.
[27] Jhang JF, Hsu YH, Kuo HC. Possible pathophysiology of ketamine-related cystitis and associated treatment strategies[J]. Int J Urol, 2015, 22(9): 816-825.
[28] Chung SD, Wang CC, Kuo HC. Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain[J]. Neurourol Urodyn, 2014, 33(8): 1207-1211.
[29] Huang LK, Wang JH, Shen SH, et al. Evaluation of the extent of ketamine-induced uropathy: the role of CT urography[J]. Postgrad Med, 2014, 90(1062): 185-190.
[30] Mason K, Cottrell AM, Corrigan AG, et al. Ketamine-associated lower urinary tract destruction: a new radiological challenge [J].Clin Radiol, 2010, 65(10): 795-800.
[31] Chuang SM, Liu KM, Li YL, et al. Dual involvements of cyclooxygenase and nitric oxide synthase expressions in Ketamine-Induced ulcerative cystitis in rat bladder [J]. Neurourol Urodyn, 2013, 32(8): 1137-1143.
[32] Lai YQ, Wua S, Ni LC, et al. Ketamine-Associated urinary tract dysfunction: an underrecognized clinical entity[J]. Urol Int, 2012,89(1): 93-96.
[33] Huang PW, Wu ST, Tsao CW, et al. Is urodynamic study a good witness to the progression of Ketamine-Associated cystitis? [J].Low Urin Tract Symptoms, 2014, 6(2): 98-102.
[34] Mak SK, Chan M., Bower WF, et al. Lower urinary tract changes in young adults using ketamine[J]. J Urol, 2011, 186(2): 610-614.
[35] Yee CH, Lai PT, Lee WM, et al. Clinical Outcome of a Prospective Case Series of Patients With Ketamine Cystitis Who Underwent Standardized Treatment Protocol [J]. Urology, 2015,86 (2):236-243.
[36] Chu PS, Ma WK, Wong SC, et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome? [J]. BJU Int,2008, 102(11): 1616-1622.
[37] Jiang S, Xie K, Cai YB. Treatment ketamine-related bladder dysfunction by intravesical injection of botulinum toxin A [J]. J Third Mil Med Univ，2012, 34(11): 1120-1122.
[38] Chang T, Lin C, Teg A, et al. Ketamine-induced uropathy: a new clinical entity causing lower urinary tract symptoms [J]. LUTS，2012, 4(1):19-24.
[39] Chung SD, Wang CC, Kuo HC. Augmentation enterocystoplasty is effective in relieving refractory Ketamine-Related bladder pain[J]. Neurourol Urodyn, 2014, 33(8): 1207-1211.
[40] Ng CF, Chiu PK, Li ML, et al. Clinical outcomes of augmentation cystoplasty in patients suffering from ketamine-related bladder contractures[J]. Int Urol Nephrol, 2013, 45(5): 1245-1251.